2024-03-29T10:14:05Z
https://niigata-u.repo.nii.ac.jp/oai
oai:niigata-u.repo.nii.ac.jp:00006305
2022-12-15T03:39:37Z
453:456
471:537:568:598
In Vitro Susceptibility of Bacillus anthracis to Antimicrobial Agents Including Carbapenems and Fosfomycin
In Vitro Susceptibility of Bacillus anthracis to Antimicrobial Agents Including Carbapenems and Fosfomycin
YAMAMOTO, Tatsuo
TANEIKE, Ikue
TAMURA, Yukiko
NAKAGAWA, Saori
Bacillus anthracis
Bacillus cereus
antimicrobial agents
carbapenems
fosfomycin
in vitro susceptibility
Bacillus anthracis strains were tested for their in vitro susceptibilities to 25 antimicrobial agents, including carbapenems and fosfomycin. Ciprofloxacin, doxycycline, and amoxicillin were highly active against the B. anthracis strains, as reported earlier. Carbapenems as well as clarithromycin and clindamycin also showed considerable activity. Fosfomycin showed moderate levels of MIC against the B. anthracis strains, regardless of the presence of glucose-6-phosphate or blood. This glucose-6-phosphate-independent manner was also observed with the B. cereus strains. The data showed that, in addition to the drugs reported earlier, carbapenems are also active against B. anthracis, and that a fosfomycin-transport system in B. anthracis is distinct from the glucose-6-phosphate-inducible type in Escherichia coli or Stapylococcus aureus.
Niigata University School of Medicine
2001-09
eng
departmental bulletin paper
http://hdl.handle.net/10191/1948
https://niigata-u.repo.nii.ac.jp/records/6305
AA00508361
05677734
Acta medica et biologica
Acta medica et biologica
49
3-4
95
99
https://niigata-u.repo.nii.ac.jp/record/6305/files/KJ00001015040.pdf
application/pdf
2.2 MB
2019-08-06